Clinical Trials Directory

Trials / Completed

CompletedNCT02252250

Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer

A Prospective Cohort Study of Transanal Laparoscopic Total Mesentery Excision Versus Conventional Laparoscopic Surgery for Rectal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Third Military Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To investigates the feasibility, practicability, safety and subjective as well as functional outcome of transanal minimal invasive surgery toal mesentery excision for rectal cancer.

Detailed description

Natural orifice transluminal endoscopic surgery (NOTES) give the opportunity to reduce surgical access trauma leading to a more painless surgery and enhancing a fast postoperative recovery. Experience with transanal minimal invasive surgery(TAMIS) for rectal cancer show that such NOTES procedures are feasible and safe. And also, lots of experimental studies and small case series reporting the feasibility of transanal anterior resection with single incision laparoscopic surgery(SILS) port or other devices. However any prospective feasibility study demonstrating the safety of the procedure and functional outcomes (sphincter function, sexual function, QOF) are missing. This study investigates the feasibility, practicability, safety and subjective as well as functional outcome of transanal minimal invasive total mesentery excision for rectal cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREconventional laparoscopic total mesentery excisionconventional laparoscopic total mesentery excision
PROCEDUREtransanal hybrid-laparoscopic total mesentery excisiontransanal laparoscopic total mesentery excision for rectal cancer. Mobilize the rectum from down- to-up. Then, set a single incision laparoscopic surgery (SILS) port at the right-low abdomen to resect the lymph nodes of IMA.

Timeline

Start date
2014-10-01
Primary completion
2019-10-01
Completion
2020-11-01
First posted
2014-09-30
Last updated
2023-11-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02252250. Inclusion in this directory is not an endorsement.